Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3813

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 3813 3)

Pdp (68071 3813 3)
NuCare Pharmaceuticals offers Atorvastatin Calcium 10mg tablets with an oval, biconvex white to off-white appearance. Each tablet is engraved with "APO" on one side and "A10" on the other side. This medication is used to lower cholesterol levels and protect against heart disease. Remember to store this product at controlled room temperature and keep it out of reach of children. Contact your doctor for medical advice or report any side effects to the FDA at 1-800-FDA-1088.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
Not available.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
This is a provided table showing Cumulative Hazard (%) over time for Atorvastatin, with a hazard ratio (HR) of 0.53 (95% CI 0.45-0.83) through four years of follow-up. The data presents the percentage of patients at risk at different time points and the time to the first primary endpoint.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
This is a statistical analysis of subjects experiencing an E veri event with different treatments of Horvastatin 10mg and Sorvastatin 80mg. The results show a lower risk ratio (HR) of 0.78 for Horvastatin compared to Sorvastatin, indicating a potentially more favorable outcome with Horvastatin. Additionally, the time to the first major cardiovascular endpoint in years is being evaluated in this study.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.